6.
DAngelo E, Prat J
. Uterine sarcomas: a review. Gynecol Oncol. 2009; 116(1):131-9.
DOI: 10.1016/j.ygyno.2009.09.023.
View
7.
Major F, Blessing J, Silverberg S, Morrow C, Creasman W, Currie J
. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993; 71(4 Suppl):1702-9.
DOI: 10.1002/cncr.2820710440.
View
8.
Trope C, Abeler V, Kristensen G
. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012; 51(6):694-705.
DOI: 10.3109/0284186X.2012.689111.
View
9.
Ludovisi M, Moro F, Pasciuto T, Di Noi S, Giunchi S, Savelli L
. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound Obstet Gynecol. 2019; 54(5):676-687.
DOI: 10.1002/uog.20270.
View
10.
Pados G, Tsolakidis D, Theodoulidis V, Makedos A, Zaramboukas T, Tarlatzis B
. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women. Hum Reprod. 2017; 32(10):2036-2041.
DOI: 10.1093/humrep/dex258.
View
11.
Perkins R, Handal-Orefice R, Hanchate A, Lin M, Paasche-Orlow M
. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation. Womens Health Issues. 2015; 26(1):21-6.
DOI: 10.1016/j.whi.2015.09.008.
View
12.
Evans H, Chawla S, Simpson C, Finn K
. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988; 62(10):2239-47.
DOI: 10.1002/1097-0142(19881115)62:10<2239::aid-cncr2820621028>3.0.co;2-y.
View
13.
Al Ansari A, Al Hail F, Abboud E
. Malignant transformation of uterine leiomyoma. Qatar Med J. 2014; 2012(2):71-4.
PMC: 3991043.
DOI: 10.5339/qmj.2012.2.16.
View
14.
Yang Q, Madueke-Laveaux O, Cun H, Wlodarczyk M, Garcia N, Carvalho K
. Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells. 2024; 13(13.
PMC: 11240800.
DOI: 10.3390/cells13131106.
View
15.
Schwartz P, Kelly M
. Malignant transformation of myomas: myth or reality?. Obstet Gynecol Clin North Am. 2006; 33(1):183-98, xii.
DOI: 10.1016/j.ogc.2005.12.003.
View
16.
Stewart E, Nicholson W, Bradley L, Borah B
. The burden of uterine fibroids for African-American women: results of a national survey. J Womens Health (Larchmt). 2013; 22(10):807-16.
PMC: 3787340.
DOI: 10.1089/jwh.2013.4334.
View
17.
Kubik-Huch R, Weston M, Nougaret S, Leonhardt H, Thomassin-Naggara I, Horta M
. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas. Eur Radiol. 2018; 28(8):3125-3137.
PMC: 6028852.
DOI: 10.1007/s00330-017-5157-5.
View
18.
Casillas J, Joseph R, Guerra Jr J
. CT appearance of uterine leiomyomas. Radiographics. 1990; 10(6):999-1007.
DOI: 10.1148/radiographics.10.6.2259770.
View
19.
Bolan C, Caserta M
. MR imaging of atypical fibroids. Abdom Radiol (NY). 2016; 41(12):2332-2349.
DOI: 10.1007/s00261-016-0935-0.
View
20.
Abeler V, Royne O, Thoresen S, Danielsen H, Nesland J, Kristensen G
. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009; 54(3):355-64.
DOI: 10.1111/j.1365-2559.2009.03231.x.
View